Advanced search
Publication Cover
Tissue Barriers Volume 11, 2023 - Issue 2
Submit an article Journal homepage
1,865
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Mucosal p-STAT1/3 correlates with histologic disease activity in Crohn’s disease and is responsive to filgotinib

Walter Reinischa Division Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
View further author information
,
Adrian Seroneb Clinical Research, Gilead Sciences, Inc., Foster City, CA, USAView further author information
,
Xavier Hébuternec Department of Gastroenterology and Nutrition, Archet 2 Hospital, Centre Hospitalier Universitaire de Nice, and University Côte d’Azur, Nice, FranceView further author information
,
Tanja Kühbacherd Department of Internal Medicine, Diabetes, Pneumology, Gastroenterology, Tumor Medicine, and Palliative Medicine at the Medius Clinic in Nürtingen, Stuttgart, GermanyView further author information
,
Maria Kłopockae Department of Gastroenterology and Nutrition, NC University in Toruñ, Collegium Medicum in Bydgoszcz, Bydgoszcz, PolandView further author information
,
Xavier Roblinf Department of Gastroenterology, University Hospital of Saint Etienne, Saint-Étienne, FranceView further author information
,
Jens Brodbeckg Nonclinical Safety and Pathobiology, Gilead Sciences, Inc., Foster City, CA, USAView further author information
,
Kim Etcheversh Biostatistics Inflammation, Gilead Sciences, Inc., Foster City, CA, USAView further author information
,
René Galieni Inflammation Therapeutic Area, Galapagos SASU, Parc Biocitech, Romainville, FranceView further author information
,
Ethan Grantj Biology, Gilead Sciences, Inc, Foster City, CA, USAView further author information
,
Chantal Tassetk Late Development Portfolio, Galapagos NV, Mechelen, BelgiumView further author information
,
Oh Kyu Yoonl Clinical Bioinformatics and Exploratory Analytics, Gilead Sciences, Inc., Foster City, CA, USAView further author information
,
Shiva Zabolig Nonclinical Safety and Pathobiology, Gilead Sciences, Inc., Foster City, CA, USAView further author information
&
Séverine Vermeirem Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, BelgiumORCID Iconhttps://orcid.org/0000-0001-9942-3019View further author information
ORCID Icon show all
Article: 2088961 | Received 22 Apr 2022, Accepted 03 Jun 2022, Published online: 28 Jun 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.